XXI Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$262K Buy
502
+30
+6% +$15.4K 0.11% 204
2026
Q2
$234K Buy
472
+6
+1% +$2.66K 0.11% 200
2026
Q1
$208K Buy
+466
New +$217K 0.12% 197

Other funds holding VRTX

XXI Wealth's VRTX Position: Q3 2026 in Review

XXI Wealth increased its Vertex Pharmaceuticals (VRTX) stake by 6.4% in Q3 2026, buying an estimated $15.4K and bringing the position to 502 shares worth $262K. The position accounts for 0.11% of the portfolio, ranked #204.

XXI Wealth first reported a position in VRTX in Q1 2026 and has held it in 3 quarters since. 1,793 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • XXI Wealth held 502 shares of Vertex Pharmaceuticals worth $262K as of Q3 2026.
  • XXI Wealth bought 30 Vertex Pharmaceuticals shares in Q3 2026, an estimated $15.4K.
  • Vertex Pharmaceuticals made up 0.11% of XXI Wealth's portfolio in Q3 2026, its #204 holding.
  • XXI Wealth first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 1,793 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on XXI Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.